Lauren Schaff

19PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 01, 2026
Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial.

|Feb 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem Gliomas.

Marina Kushnirsky, Andrew L Lin, Tejus Bale

|Apr 24, 2025
Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma.

Lauren R Schaff, Anna F Piotrowski, Elena Pentsova

|Mar 13, 2025
New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Jesper Heldrup, Archie Bleyer, Laura Ramsey

|Aug 21, 2024
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma.

Kathryn R Tringale, Michael Scordo, Joachim Yahalom

|Jul 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.

Christian Grommes, Subhiksha Nandakumar, Lauren R Schaff

Pageof 4

Frequent Collaborators

10 joint publications

Christian Grommes

5 joint publications

Anne S Reiner

5 joint publications

Ingo Mellinghoff

4 joint publications

Elena Pentsova